Debabrita Deb, Ph.D.

2001 Wake Forest University School of Medicine, Winston-Salem, NC, United States 
Molecular Biology
"Debabrita Deb"


Sign in to add mentor
Sumitra Deb grad student 2001 Wake Forest School of Medicine
 (Transcriptional modulation by wild -type p53, tumor -derived mutant p53 and p73.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Scian MJ, Carchman EH, Mohanraj L, et al. (2008) Wild-type p53 and p73 negatively regulate expression of proliferation related genes. Oncogene. 27: 2583-93
Scian MJ, Stagliano KE, Deb D, et al. (2004) Tumor-derived p53 mutants induce oncogenesis by transactivating growth-promoting genes. Oncogene. 23: 4430-43
Deb D, Scian M, Roth KE, et al. (2002) Hetero-oligomerization does not compromise 'gain of function' of tumor-derived p53 mutants. Oncogene. 21: 176-89
Brown DR, Deb D, Frum R, et al. (2001) The human oncoprotein MDM2 uses distinct strategies to inhibit transcriptional activation mediated by the wild-type p53 and its tumor-derived mutants. International Journal of Oncology. 18: 449-59
Deb D, Lanyi A, Scian M, et al. (2001) Differential modulation of cellular and viral promoters by p73 and p53. International Journal of Oncology. 18: 401-9
Deb D, Chakraborti AS, Lányi A, et al. (1999) Disruption of functions of wild-type p53 by hetero-oligomerization. International Journal of Oncology. 15: 413-22
Lányi A, Deb D, Seymour RC, et al. (1998) 'Gain of function' phenotype of tumor-derived mutant p53 requires the oligomerization/nonsequence-specific nucleic acid-binding domain. Oncogene. 16: 3169-76
See more...